NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE179348 Query DataSets for GSE179348
Status Public on Feb 12, 2022
Title Structural basis for PoxtA-mediated resistance to Phenicol and Oxazolidinone antibiotics 
Organism Enterococcus faecalis
Experiment type Other
Summary PoxtA and OptrA are ATP binding cassette (ABC) proteins of the F subtype (ABCF) that confer resistance to oxazolidinone, such as linezolid, and phenicol antibiotics, such as chloramphenicol. PoxtA/OptrA are often encoded on mobile genetic elements, facilitating their rapid spread amongst Gram-positive bacteria. These target protection proteins are thought to confer resistance by binding to the ribosome and dislodging the antibiotics from their binding sites. However, a structural basis for their mechanism of action has been lacking. Here by investigating 5'P mRNA decay intermediates, that provide ribosome protection data, we show that PoxtA protects against Linezolid specific stalls. Furthermore, we present cryo-electron microscopy structures of PoxtA in complex with the Enterococcus faecalis 70S ribosome at 2.9–3.1 Å, as well as the complete E. faecalis 70S ribosome at 2.2–2.5 Å. The structures reveal that PoxtA binds within the ribosomal E-site with its antibiotic resistance domain (ARD) extending towards the peptidyltransferase center (PTC) on the large ribosomal subunit. At its closest point, the ARD of PoxtA is still located >15 Å from the linezolid and chloramphenicol binding sites, suggesting that drug release is elicited indirectly. Instead, we observe that the ARD of PoxtA perturbs the CCA-end of the P-site tRNA causing it to shift by ~4 Å out of the PTC, which correlates with a register shift of one amino acid for the attached nascent polypeptide chain. Given that linezolid and chloramphenicol are context-specific translation elongation inhibitors, we postulate that PoxtA/OptrA confer resistance to oxazolidinones and phenicols indirectly by perturbing the P-site tRNA and thereby altering the conformation of the attached nascent chain to disrupt the drug binding site.
 
Overall design Here we investigate 5'P mRNA decay intermediates in Enterococcus faecalis to investigate context-specific ribosome stalls in response to Linezolid in presence or absence of PoxtA. We analyzed 12 samples using HT-5PSeq (Zhang and Pelechano, https://doi.org/10.1016/j.crmeth.2021.100001) optimized for bacteria (Huch, Nersisyan et al, https://doi.org/10.1101/2021.04.08.439066). We performed three biological replicates for two strains (with and without PoxtA expression) in the presence and absence of Linezolid treatment at sub-MIC concentrations.
 
Contributor(s) Crowe-McAuliffe C, Murina V, Kasari M, Turnbull KJ, Takada H, Polikanov YS, Sunsfjord A, Hegstad K, Atkinson GC, Hauryliuk V, Wilson DN, Huch S, Nersisyan L, Pelechano V
Citation(s) 35387982
Submission date Jul 02, 2021
Last update date Apr 27, 2022
Contact name Vicent Pelechano
E-mail(s) vicente.pelechano.garcia@ki.se
Organization name ScilifeLab - Karolinska Institutet
Department MTC
Street address Nobels väg 16
City Solna
ZIP/Postal code SE-17177
Country Sweden
 
Platforms (1)
GPL30343 NextSeq 2000 (Enterococcus faecalis)
Samples (12)
GSM5415986 efae_poxTA_LZD_rep01
GSM5415987 efae_poxTA_LZD_rep02
GSM5415988 efae_poxTA_LZD_rep03
Relations
BioProject PRJNA743321
SRA SRP326687

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE179348_RAW.tar 7.3 Mb (http)(custom) TAR (of BEDGRAPH)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap